Cancer
Claims are largely preclinical; this is not human treatment evidence.
Inonotus obliquus
Chaga has a large reputation and a much smaller human evidence base. The sources reviewed discuss laboratory and animal findings, but we did not identify convincing human clinical efficacy evidence for treating a health condition.
Evidence snapshot reviewed October 16, 2026
Research connections
Claims are largely preclinical; this is not human treatment evidence.
Published case reports describe oxalate nephropathy after heavy use.
Biological interest is mainly based on laboratory and animal work.
Reviewed evidence
We are not filling this space with traditional claims, mechanisms, or animal findings and calling them human benefit. The profile above states what the reviewed sources can support today.
Profile sources